1. Home
  2. CADL vs WDI Comparison

CADL vs WDI Comparison

Compare CADL & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$8.34

Market Cap

641.2M

Sector

Health Care

ML Signal

N/A

Logo Western Asset Diversified Income Fund of Beneficial Interest

WDI

Western Asset Diversified Income Fund of Beneficial Interest

N/A

Current Price

$11.59

Market Cap

610.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
WDI
Founded
1999
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
641.2M
610.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
WDI
Price
$8.34
$11.59
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $22.11
N/A
AVG Volume (30 Days)
★ 905.6K
406.1K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 11.80%
EPS Growth
★ 58.62
N/A
EPS
N/A
★ 1.12
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.41
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$11.34
52 Week High
$14.00
$14.51

Technical Indicators

Market Signals
Indicator
CADL
WDI
Relative Strength Index (RSI) 36.89 42.17
Support Level $7.70 $11.50
Resistance Level $9.42 $11.98
Average True Range (ATR) 0.54 0.12
MACD 0.06 0.04
Stochastic Oscillator 27.27 65.00

Price Performance

Historical Comparison
CADL
WDI

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About WDI Western Asset Diversified Income Fund of Beneficial Interest

Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.

Share on Social Networks: